Directory
>
Jennifer Webster
Jennifer Webster
Sr. Vice President, Clin. Dev. Ops. & Patient Engagement | Remix Therapeutics
Boston, Massachusetts, United States
Jennifer Webster
Summary
Jennifer Webster is a seasoned executive in the pharmaceutical and life sciences sectors, specializing in clinical development and operations. With a strong strategic vision and operational acumen, she has successfully led teams in the development and launch of several first-in-class therapies across various disease areas, including oncology and rare diseases. Her extensive experience spans from pre-clinical trials to product launch, showcasing her ability to navigate complex regulatory landscapes and foster high-yield collaborations. Jennifer is known for her passion for delivering impactful solutions that benefit patients and drive business success. She holds an MBA from the University of Massachusetts Boston and a BA in Psychology from the University of Rochester. Her leadership style emphasizes cross-functional teamwork and effective communication, making her a valuable asset in any organization.
Jennifer Webster
Work Experience
Sr. Vice President, Clin. Dev. Ops. & Patient Engagement at
Remix Therapeutics
December 2022 - Present
Vice President, Program Lead at
Fulcrum Therapeutics
September 2021 - August 2022
Vice President at
Foundation Medicine
February 2016 - April 2021
Associate Director at
Takeda Oncology
October 2014 - January 2016
Associate Director, Medical Alliances & Grants at
Vertex Pharmaceuticals
January 2011 - January 2013
Sr Clinical Program Manager, Clinical Project Leader, Clinical Trials Manager at
Vertex Pharmaceuticals
January 2006 - January 2011
Sr Outsourcing Manager, Outsourcing Manager at
Vertex Pharmaceuticals
January 2004 - January 2006
Sr Associate, Business Operations, Worldwide Regulatory Affairs at
Parexel International
January 2002 - January 2004
Sr Proposal Associate, Proposal Associate at
Parexel International
January 2001 - January 2002
Clinical Research Assistant at
Parexel International
January 1999 - January 2001
Jennifer Webster
Education
University of Massachusetts Boston, Master Of Business Administration (Mba)
University of Rochester, Bachelor Of Arts (B.A.)
Milton Academy
Frequently Asked Questions about Jennifer Webster
What is Jennifer Webster email address?
Jennifer Webster's primary email address is ********@remixtx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Jennifer Webster work for?
Jennifer Webster is a Sr. Vice President, Clin. Dev. Ops. & Patient Engagement at Remix Therapeutics.
Where Jennifer Webster graduated from?
Jennifer Webster holds a degree in from University of Massachusetts Boston.
How can I directly contact Jennifer Webster?
To contact Jennifer Webster directly, you can use the email address ********@remixtx.com. Complete contact information is available upon registration with Muraena.
Who is Jennifer Webster?
Jennifer Webster is a seasoned executive in the pharmaceutical and life sciences sectors, specializing in clinical development and operations. With a strong strategic vision and operational acumen, she has successfully led teams in the development and launch of several first-in-class therapies across various disease areas, including oncology and rare diseases. Her extensive experience spans from pre-clinical trials to product launch, showcasing her ability to navigate complex regulatory landscapes and foster high-yield collaborations. Jennifer is known for her passion for delivering impactful solutions that benefit patients and drive business success. She holds an MBA from the University of Massachusetts Boston and a BA in Psychology from the University of Rochester. Her leadership style emphasizes cross-functional teamwork and effective communication, making her a valuable asset in any organization.
Jennifer`s contact details
********@remixtx.com
********@fulcrumtx.com
Colleagues
Chief Scientific Officer
Vice President, Head of Program and Alliance Management
Senior Vice President, Head of Early Research
COO/CBO
Board Member